Veracyte
VCYT
VCYT
79 hedge funds and large institutions have $158M invested in Veracyte in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $207M → $158M (-$49M)
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
95% less call options, than puts
Call options by funds: $48K | Put options by funds: $987K
Holders
79
Holding in Top 10
3
Calls
$48K
Puts
$987K
Top Buyers
| 1 | +$5.97M | |
| 2 | +$5.91M | |
| 3 | +$3.81M | |
| 4 |
First Manhattan
New York
|
+$1.78M |
| 5 |
CC
Cannell Capital
Alta,
Wyoming
|
+$1.63M |
Top Sellers
| 1 | -$6.03M | |
| 2 | -$4.6M | |
| 3 | -$3.41M | |
| 4 |
BC
Broadfin Capital
New York
|
-$1.79M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$1.49M |